KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Curent Deferred Tax Liability (2011 - 2014)

Edwards Lifesciences' quarterly Curent Deferred Tax Liability came in at $8.3 million in Q4 2014, up 15.28% year-on-year from $7.2 million in Q4 2013, and up 16.9% quarter-over-quarter from $7.1 million in Q3 2014.

Edwards Lifesciences has reported Curent Deferred Tax Liability for 4 years, with the latest figure at $8.3 million in Q4 2014.

  • For the quarter ending Q4 2014, Curent Deferred Tax Liability rose 15.28% year-over-year to $8.3 million; the trailing twelve-month figure through Dec 2014 stood at $8.3 million (up 15.28% YoY), and the FY2014 full-year result was $8.3 million, up 15.28% from the prior year.
  • Curent Deferred Tax Liability for Q4 2014 stood at $8.3 million, up from $7.1 million in the prior quarter.
  • The five-year high for Curent Deferred Tax Liability was $8.7 million in Q4 2012, with the low at $7.1 million in Q3 2014.
  • Average Curent Deferred Tax Liability over 4 years is $8.0 million, with a median of $8.3 million recorded in 2014.
  • Year-over-year, Curent Deferred Tax Liability fell 17.24% in 2013 and grew 15.28% in 2014.
  • Tracing EW's Curent Deferred Tax Liability over 4 years: stood at $8.6 million in 2011, then rose by 1.16% to $8.7 million in 2012, then slipped by 17.24% to $7.2 million in 2013, then rose by 15.28% to $8.3 million in 2014.
  • The last three Curent Deferred Tax Liability figures came in at $8.3 million (Q4 2014), $7.1 million (Q3 2014), and $7.2 million (Q4 2013), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Curent Deferred Tax (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2014 8.30 Mn
Dec 31, 2014 8.30 Mn
Sep 30, 2014 7.10 Mn
Sep 30, 2014 7.10 Mn
Dec 31, 2013 7.20 Mn
Dec 31, 2013 7.20 Mn
Dec 31, 2012 8.70 Mn
Dec 31, 2012 8.70 Mn
Dec 31, 2011 8.60 Mn
Dec 31, 2011 8.60 Mn